Evidence map›Paper›PMID 34524582›Full record

ArticleChild psychiatry and human development2023

Use of Medication to Treat Attention-Deficit/Hyperactivity Disorder in Young Children: The Role of Maternal History of Psychotropic Medication Use.

Elizabeth Wall-Wieler, James M Bolton, Gilles Detillieux, Leslie L Roos

Abstract read
PubMed Publisher
In one paragraph

Article in Child psychiatry and human development, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Elizabeth Wall-WielerDepartment of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada. elizabeth.wall-wieler@umanitoba.ca.ORCID 0000-0003-2480-8875
James M BoltonDepartment of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Gilles DetillieuxManitoba Centre for Health Policy, University of Manitoba, Winnipeg, MB, Canada.
Leslie L RoosDepartment of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Manitoba Health · CAUniversity of Manitoba · CA

Funding

CIHR PJT-162111
6 · The paper itself

Abstract

We examine whether, among children diagnosed with ADHD, are those whose mothers have a history of psychotropic medication use more likely to treat their ADHD with medication? Children born in Manitoba, Canada from 2000 to 2010 diagnosed with ADHD between their 4th and 8th birthday. Maternal psychotropic medication use was assessed from one year before the child's birth to the child's fourth birthday. Logistic regression models examine the relationship between maternal history of psychotropic medication use and the use of medication to treat ADHD in children. Among the 2384 children diagnosed with ADHD, the rate of ADHD medication use was higher for those whose mother had a history of psychotropic medication use (76.6%) than for those whose mothers did not (72.5%) (OR 1.24, 95% CI 1.03, 1.49). Children whose mothers have a history of psychotropic medication use are more likely to have their ADHD treated with medication.

Indexed as

Attention Deficit Disorder with HyperactivityCanadaChildChild, PreschoolFemaleHumansMothersPsychotropic DrugsPsychotropic DrugsADHDCohort studyMaternal and child healthPsychotropic medication

Identifiers

PMID34524582
OpenAlexW3201494657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.